article thumbnail

2024 Nobel Prize winner Gary Ruvkun on sharing credit and the future of microRNA

STAT

Scientists have since built on the duo’s work, published in 1993, to study cancer treatments, diabetes, and metabolism.  The conversation has been edited for length and clarity.

article thumbnail

Wearable technology to be offered to thousands with type 1 diabetes in UK

Pharma Times

The National Institute for Health and Care Excellence (NICE) has published final guidance announcing a five-year roll-out of a wearable technology for patients living with type 1 diabetes. The new hybrid closed loop systems have proven to be more effective in maintaining healthy blood glucose levels than standard care.

Diabetes 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: New weight loss drugs are changing the narrative on obesity, with a push from pharma

STAT

This is the first article in a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

article thumbnail

Jardiance® improves blood sugar control in type 2 diabetes

European Pharmaceutical Review

percent when used alongside other baseline treatments (diet, exercise, metformin and/or insulin), compared with placebo in a Phase III clinical trial of children and adolescents aged 10-17 years with type 2 diabetes. What is your opinion on Jardiance ® (empagliflozin) becoming another option for managing type 2 diabetes?

article thumbnail

Digital monitoring could be a leveller in diabetes therapy

pharmaphorum

A digital tool developed by DarioHealth has been shown to help patients with type 2 diabetes manage their blood sugar more effectively, regardless of their demographic background, in a new study. The post Digital monitoring could be a leveller in diabetes therapy appeared first on.

article thumbnail

SAEM Clinical Images Series: Blue is Bad

ALiEM - Pharm Pearls

66 year-old-male with a history of type 2 diabetes and hypertension presented as a transfer for rapid progression of lower extremity pain, swelling, and blue-purple discoloration of the entire limb with concern for a possible necrotizing infection. His symptoms began earlier in the day and progressed over just a few hours.

article thumbnail

SAEM Clinical Images Series: Penile Lesion with a Poor Prognosis

ALiEM - Pharm Pearls

Author information Kyrillos Attaalla, MD Resident Physician Rutgers - New Jersey Medical School | The post SAEM Clinical Images Series: Penile Lesion with a Poor Prognosis appeared first on ALiEM. View other cases from this Clinical Image Series on ALiEM.

Hospitals 152